Silence Therapeutics (SLN) Change in Cash (2024 - 2026)
Silence Therapeutics (SLN) reported Change in Cash of -$5.6 million for Q1 2026, up 90.11% on a YoY basis from -$2.9 million in Q1 2025, and up 92.07% sequentially from -$70.6 million in Q4 2025.
Silence Therapeutics (SLN) Change in Cash (2024 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 3 years of Change in Cash data on file, last reported at -$5.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash rose 90.11% year-over-year to -$5.6 million; the trailing twelve-month figure through Mar 2026 stood at -$59.2 million (up 24.29% YoY), and the FY2025 full-year result was -$110.2 million, down 310.07% from the prior year.
- Change in Cash improved to -$5.6 million in Q1 2026, from -$70.6 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $74.0 million in Q1 2024 to a low of -$70.6 million in Q4 2025.
- A 3-year average of -$7.0 million and a median of -$5.6 million in 2026 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 172.43% in 2025, while the deepest fall reached 448.13% in 2025.
- Tracing SLN's Change in Cash over 3 years: stood at $38.5 million in 2024, then sank by 283.22% to -$70.6 million in 2025, then jumped by 92.07% to -$5.6 million in 2026.
- Business Quant data shows SLN's Change in Cash at -$5.6 million in Q1 2026, -$70.6 million in Q4 2025, and $40.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 | -5.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.60 Mn |
| Dec 31, 2025 | -70.63 Mn |
| Sep 30, 2025 | 40.40 Mn |
| Jun 30, 2025 | -23.35 Mn |
| Mar 31, 2025 | -56.68 Mn |
| Dec 31, 2024 | 38.55 Mn |
| Sep 30, 2024 | -55.78 Mn |
| Jun 30, 2024 | -4.26 Mn |
| Mar 31, 2024 | 73.97 Mn |